Abstract
Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, evaluates novel treatment approaches in relapsed/refractory mantle cell lymphoma, as presented by Kami J. Maddocks, MD, of Ohio State University, at the 2021 SOHO Annual Meeting.
